Table 2.
Lymphoepithelioma-like carcinoma of the urinary bladder: clinical and pathological results in 93 cases
| Features | Patient population | |
|---|---|---|
| Sex | (n = 65) | |
| Male | 48 (74%) | |
| Female | 17 (26%) | |
| Age | (n = 62) | |
| Mean | 70.0 | |
| Range | 52-90 | |
| Chief complaint | (n = 35) | |
| GH | 31 (88%) | |
| GH and Urgency | 3 (9%) | |
| GH and Miction pain | 1 (3%) | |
| Histology | (n = 90) | |
| Pure | 39 (43%) | |
| Predominant | 26 (29%) | |
| Focal | 13 (15%) | |
| Mixed | 12 (13%) | |
| Pathological stage (T) | (n = 92) | |
| T1 | 14 (15%) | |
| T2 | 52 (56%) | |
| T3 | 24 (27%) | |
| T4 | 2 (2%) | |
| Primary treatment | (n = 92) | |
| TURBT | 51 (55%) | |
| Partial cystectomy | 6 (7%) | |
| Radical cystectomy | 35 (38%) | |
| Adjuvant treatment | (n = 92) | |
| Systemic chemotherapy | 21 (23%) | |
| Radiotherapy | 14 (15%) | |
| Chemoradiotherapy | 6 (7%) | |
| Intravesical chemotherapy | 3 (3%) | |
| Not performed | 48 (52%) | |
| Follow-up | (n = 87) | |
| Mean | 30.4 (months) | |
| Range | 0-216 (months) | |
| Outcome | (n = 87) | |
| Not evidence of disease (NED) | 59 (67%) | |
| Died of disease (DOD) | 14 (17%) | |
| Died without disease (DWD) | 9 (10%) | |
| Alive with metastases (AWM) | 5 (6%) | |
| Cause-specific survival rate | 83% |
GH Gross hematuria, TURBT Transurethral resection of the bladder tumor.